Skip to main content
Signal8
Launch Terminal

Glucotrack, Inc. (GCTK)

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

GlucoTrack, Inc. logo

GlucoTrack, Inc.

NASDAQ:GCTKHealthcare
-41.73%$0.8100
Mkt Cap$959K
Float1.09M
O/S1.18M
Vol
$ Vol
RVOL
Inst Own1.6%
Earnings
Dilution
GlucoTrack, Inc. logoNASDAQ:GCTK$0.8100-41.73%
Pipeline3 lead-sponsored trials·1 active0 completed

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Status
Phase
  • Phase 1/2
    Unknown status

    Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device

    GlucoTrack

    Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

    Enrollment
    180
    Start
    May 2009
    Primary Completion
    Oct 2012est.
    Completion
    Oct 2012est.
    NCT00889668
  • Not applicable
    Unknown status

    Evaluation of the GlucoTrack, Non-Invasive Glucose Monitoring Device

    GlucoTrack

    Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus +1

    Enrollment
    142
    Start
    Dec 2006
    Primary Completion
    -
    Completion
    Dec 2008est.
    NCT00433758
  • Not applicable
    Recruiting

    Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor

    Sensor Lead

    Diabetes Mellitus

    Enrollment
    10
    Start
    Dec 2024
    Primary Completion
    Feb 2025est.
    Completion
    Feb 2025est.
    NCT06764069
Search ClinicalTrials.gov for “Glucotrack”